Stocks and Investing Stocks and Investing
Wed, July 28, 2021
Tue, July 27, 2021
Mon, July 26, 2021
Fri, July 23, 2021

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $128 on, Jul 23rd, 2021


Published on 2024-10-27 17:18:41 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $116 to $128 on, Jul 23rd, 2021.

Jayson has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 2 agree with Jayson's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $128 on, Tuesday, July 20th, 2021
  • James Mainwaring of "Atlantic Equities" Initiated at Hold and Held Target at $122 on, Thursday, April 15th, 2021


These are the ratings of the 8 analyists that currently disagree with Jayson


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $135 on, Wednesday, July 21st, 2021
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $126 on, Tuesday, July 20th, 2021
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $125 on, Friday, June 4th, 2021
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Wednesday, June 2nd, 2021
  • Travis Steed of "Barclays" Maintained at Buy with Decreased Target to $125 on, Wednesday, June 2nd, 2021
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Decreased Target to $127 on, Tuesday, June 1st, 2021
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $140 on, Wednesday, April 21st, 2021